United States · 
Who invested in NRx Pharmaceuticals?
NRx Pharmaceuticals's investors include B Capital.
United States · Funded startup
Who invested in NRx Pharmaceuticals
Funding summaryUpdated 26 Oct 2026
$22Mraised across 1 round since 2026, from 1 source
- Latest round
- Round, $22MJun 2026
- Investors
- 1
The rounds
- Jun 2026
Founders and team
From NRx Pharmaceuticals's own website: 1 founder, 4 on the team.
Chaim HurvitzFounder, Chairman & Chief Scientist; Co-CEO HOPE Therapeutics
- Glenn D. TysonChief Commercial Officer
- Michael AbramsChief Financial Officer
- Michael TaylorChief Development Officer
- Patrick FlynnAudit Committee Chair
AdvisersWayne Pines
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about NRx Pharmaceuticals
How much has NRx Pharmaceuticals raised?
NRx Pharmaceuticals has raised $22M across 1 round since 2026.
When did NRx Pharmaceuticals last raise?
NRx Pharmaceuticals's most recent round was an Undisclosed round of $22M in Jun 2026.
What was NRx Pharmaceuticals's biggest round?
Its most recent round, $22M in Jun 2026, is also its largest on record.
Who backed NRx Pharmaceuticals first?
NRx Pharmaceuticals's first round on record, in Jun 2026, was backed by B Capital.
What stage is NRx Pharmaceuticals at?
NRx Pharmaceuticals's latest named round is an Undisclosed round, in Jun 2026.
Where is NRx Pharmaceuticals based?
NRx Pharmaceuticals is based in the United States.
Companies like NRx Pharmaceuticals
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.